Literature DB >> 32580930

Commercial influence and covid-19.

Ray Moynihan1, Helen Macdonald2, Lisa Bero3, Fiona Godlee2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32580930     DOI： 10.1136/bmj.m2456

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic.

Authors:  Émilien Schultz; Léo Mignot; Jeremy K Ward; Daniela Boaventura Bomfim; Christian Chabannon; Julien Mancini
Journal:  Therapie       Date:  2022-05-07       Impact factor: 3.367

2.  The Pharmaceutical Year That Was, 2020.

Authors:  Anthony W Fox
Journal:  Pharmaceut Med       Date:  2020-12

3.  Determinants of Infodemics During Disease Outbreaks: A Systematic Review.

Authors:  Javier Alvarez-Galvez; Victor Suarez-Lledo; Antonio Rojas-Garcia
Journal:  Front Public Health       Date:  2021-03-29

Review 4.  Looking back and moving forward: Addressing health inequities after COVID-19.

Authors:  Kimberlyn McGrail; Jeffrey Morgan; Arjumand Siddiqi
Journal:  Lancet Reg Health Am       Date:  2022-03-17

Review 5.  Ethical and regulatory implications of the COVID-19 pandemic for the medical devices industry and its representatives.

Authors:  Brette Blakely; Wendy Rogers; Jane Johnson; Quinn Grundy; Katrina Hutchison; Robyn Clay-Williams; Bernadette Richards; Guy Maddern
Journal:  BMC Med Ethics       Date:  2022-03-23       Impact factor: 2.652
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.